• SPX
  • $5,505.00
  • -0.71 %
  • -$39.59
  • DJI
  • $40,287.53
  • -0.93 %
  • -$377.47
  • N225
  • $40,063.79
  • -0.16 %
  • -$62.61
  • FTSE
  • $8,155.72
  • -0.6 %
  • -$49.17
  • IXIC
  • $17,726.94
  • -0.81 %
  • -$144.28

Baxter International Inc. (BAX) Stock Price, News & Analysis

Currency in USD Disclaimer

$35.35

-$0.33

(-0.93%)

Day's range
$35.17
$35.87
50-day range
$32.48
$36.37
  • Country: US
  • ISIN: US0718131099
52 wk range
$31.01
$49.4
BAX Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 2.07
  • Piotroski Score 6.00
  • Grade Neutral
  • Symbol (BAX)
  • Company Baxter International Inc.
  • Price $35.35
  • Changes Percentage (-0.93%)
  • Change -$0.33
  • Day Low $35.17
  • Day High $35.87
  • Year High $49.40

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

  • Last Earnings 07/16/2024
  • Ex-Dividend for 5/16 Dividend 08/30/2024
  • Dividend Payable 10/01/2024
  • Today N/A
  • Next Earnings (Estimated) 08/06/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $54.00
  • High Stock Price Target $100.00
  • Low Stock Price Target $30.00
  • Potential Upside/Downside N/A
  • Consensus Rating Buy
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.08
  • Trailing P/E Ratio -414.5
  • Forward P/E Ratio -414.5
  • P/E Growth -414.5
  • Net Income $2.66 B

Income Statement

Quarterly

Annual

Latest news of BAX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.